These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing, reported early 2004-000063-10 A comparison of Metvix PDT with simple excision surgery in subjects with superficial Basal cell Carcinoma (sBCC) not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-000700-41 Comparison of Metvix® PDT with Cryotherapy in Subjects with Actinic Keratoses on locations other than the face and scalp 2006-02-16 bad-data
Ongoing 2004-003015-23 Estudio de la eficacia y seguridad de la Terapia Fotodinámica con Metil Aminolevulinato en crema (Metvix®) en pacientes de alto riesgo con Carcinoma Basocelular Superficial (CBCs). not-yet-due
Ongoing, reported early 2005-005769-12 FLUORESCENT DETECTION WITH METHYL AMINOLEVULINATE OF BASAL CELL CARCINOMA: TO ASSESS THE ACCURACY OF THIS TECHNIQUE BY COMPARISON WITH RESECTION MARGIN LEFT BY MOH’S MICROGRAPHIC SURGERY AFTER DIFFER... not-yet-due
Reported results 2006-000974-54 A multi-centre, randomized, parallel groups, vehicle and active controlled study of amorolfine 4% and 10% nail lacquer new formulation in the topical treatment of distal and lateral subungual toenail ... 2008-05-15 due-trials
Reported results 2006-001999-20 ASSESSMENT OF THE EFFICACY AND SAFETY OF THREE CONCENTRATIONS: 1%, 0.3%, 0.1% OF CD5024 CREAM ONCE DAILY AND CD5024 1% CREAM TWICE DAILY, VERSUS ITS VEHICLE AND VERSUS METRONIDAZOLE 0.75% CREAM (ROZEX... 2007-06-18 due-trials
Ongoing 2006-003073-27 Subject preference comparison between Clobetasol propionate shampoo, 0.05 and three other topical corticosteroids in the treatment of moderate to severe scalp psoriasis not-yet-due
Reported results 2006-003156-37 AN EXPLORATORY STUDY TO EVALUATE RELAPSES FOLLOWING AN INITIAL 12 WEEKS DOSE-RANGE STUDY WITH CD5024 CREAM VERSUS ITS VEHICLE AND VERSUS METRONIDAZOLE 0.75% CREAM IN PAPULO-PUSTULAR ROSACEA – A 6 MONT... 2007-11-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003707-40 Activity of twice daily per os administration of CD06713 at 8mg versus its placebo during 4 weeks treatment, in patients with erythemato-telangiectatic rosacea. 2007-05-23 bad-data
Reported results 2006-004215-21 A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO DEMONSTRATE THE EFFICACY AND SAFETY OF ADAPALENE/BENZOYL PEROXIDE TOPICAL GEL COMPARED WITH ADAPALENE TOPICAL GEL, 0.1%; BENZOYL PEROX... 2007-10-05 due-trials
Reported results 2006-004237-15 Comparison of Metvix® PDT with its vehicle in the treatment of photoaged skin 2008-09-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004278-28 Efficacy and safety of a fixed combination Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel compared to Clindamycin 1% / Benzoyl Peroxide 5% Gel in the treatment of acne vulgaris. 2007-10-16 bad-data
Ongoing, reported early 2006-006487-32 CLINICAL EFFICACY EVALUATION OF A FIXED COMBINATION OF CALCITRIOL 3 µg/g WITH THREE CONCENTRATIONS (100, 250, 500µg/g) OF CLOBETASOL PROPIONATE AS SPRAY FORMULATION USING THE MODIFIED DUMAS-SCHOLTZ PS... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-006673-91 A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF CD5024 1% CREAM TREATMENT FOR UP TO 52 WEEKS IN SUBJECTS WITH PAPULOPUSTULAR ROSACEA 2009-02-17 bad-data
Ongoing 2007-007789-39 Efficacy and safety comparison of CD4802 0.1% ointment versus vehicle in the treatment of target lesions in adults with atopic dermatitis not-yet-due
Ongoing, reported early 2008-001603-30 Gene expression in renal transplant patients with field Actinic Keratosis undergoing Metvix® PDT not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-002679-29 Plasma Pharmacokinetics study of CD5024 1% cream in subjects with papulopustular rosacea 2008-12-01 bad-data
Ongoing 2008-003854-13 AN INVESTIGATOR BLIND PARALLEL GROUP VEHICLE CONTROL STUDY COMPARING THE EFFICACY AND SAFETY OF CD 5024 1% CREAM WITH METRONIDAZOLE 0.75% CREAM IN SUBJECTS WITH PAPULOPUSTULAR ROSACEA OVER 16 W... not-yet-due
Reported results 2008-005217-22 Efficacy and Safety of Clobetasol propionate shampoo 0.05% used in association with an antifungal shampoo in the treatment of moderate to severe Scalp Seborrheic Dermatitis 2010-02-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-006792-68 Efficacy and Safety comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel associated with Lymecycline 300mg Capsules versus Adapalene 0.1% / Benzoyl Peroxide 2.5% Vehicle Gel associated with Lymecy... 2010-04-15 bad-data
Ongoing, reported early 2008-007981-44 EXPLORATORY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CD5789 IN SUBJECTS WITH ACNE not-yet-due
Not reported 2009-010338-23 Intra-individual randomized comparison of the efficacy of two botulinum toxins type A on moderate to severe forehead wrinkles after one injection 2010-05-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-010498-19 A MULTICENTER, RANDOMIZED, INTRA-INDIVIDUAL, DOUBLE BLIND, VEHICLE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CD2027 OINTMENT 9µG/G APPLIED TWICE DAILY OVER 4 WEEKS IN THE TREATMENT OF TA... 2009-11-16 bad-data
Reported results 2009-011212-37 Anti P. acnes activity of Epiduo® Gel compared to Benzoyl Peroxide 2.5% Gel in the treatment of subjects with acne vulgaris 2010-08-23 due-trials
Reported results 2009-013111-35 EFFECT OF CD08514 VERSUS PLACEBO, IN PATIENTS PRESENTING WITH TYPE 1 ROSACEA, OVER AN 8-WEEK TREATMENT 2010-06-07 due-trials
Reported results 2010-018319-13 A DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL GROUP STUDY ASSESSING THE ACTIVITY OF CD5024 1% CREAM IN SUBJECTS WITH PAPULOPUSTULAR ROSACEA OVER 12 WEEKS TREATMENT 2011-05-02 due-trials
Ongoing, reported early 2010-019994-13 EXPLORATORY STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CD07387 SOLUTION IN PATIENTS WITH VITILIGO not-yet-due
Reported results 2010-021936-33 A multi-center randomized, double-blind, placebo controlled, parallel-group study of CD 07743 for the improvement of Lateral Canthal Lines (crow’s feet) 2012-05-02 due-trials
Reported results 2010-022211-19 PILOT STUDY TO EXPLORE EFFICACY AND SAFETY OF DIFFERENT DOSE REGIMENS OF CD5789 IN SUBJECTS WITH ACNE VULGARIS 2011-06-24 due-trials
Reported results 2010-024214-54 Exploratory study to assess facial tolerability after daily application of several concentrations and formulations containing CD5789 in acne subjects 2011-07-25 due-trials
Reported results 2011-002057-65 Effect of CD08100/02 3% gel versus placebo in subjects presenting with erythematotelangiectatic rosacea over a 4 week treatment period. 2011-12-23 due-trials
Reported results 2011-002058-30 Effect of CD08100/02 3% gel versus placebo gel in subjects presenting with papulopustular rosacea over a 6-week treatment period. 2012-03-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-004592-36 Subjects’ satisfaction on pan facial aesthetic enhancement after treatment with Azzalure® and the Restylane® range 2013-04-16 bad-data
Reported results 2011-004791-11 Efficacy and safety of CD5024 1% cream versus metronidazole 0.75% cream in subjects with papulopustular rosacea over 16 weeks treatment, followed by a 36-week extension period 2013-12-19 due-trials
Reported results 2012-001044-22 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL GROUP STUDY TO DEMONSTRATE THE EFFICACY AND ASSESS THE SAFETY OF CD07805/47 GEL 0.5% APPLIED TOPICALLY ONCE DAILY IN SUBJECTS WITH... 2013-10-18 due-trials
Not reported 2012-005686-12 Patient-reported outcomes of Brimonidine Tartrate 0.5% gel for treatment of severe facial erythema of rosacea 2013-11-19 due-trials
Not reported 2013-000544-26 Determination of antifungal activity of Loceryl® Nail Lacquer 5% when used concomitantly with a cosmetic nail varnish compared to a Loceryl® Nail Lacquer 5% alone in treatment of toenail Distal Subung... 2016-01-21 due-trials
Listed as ongoing, but also has a completion date 2013-000973-54 Multi-centre, randomized, investigator-blind, intra-individual active and vehicle-controlled study, comparing Metvix® Natural Daylight Photodynamic Therapy versus Metvix® conventional Photodynamic The... 2014-01-06 bad-data
Completed, but no date 2013-001796-20 Efficacy, safety and pharmacokinetics of 2 concentrations and 2 dosage regimens of CD5789 in subjects with Lamellar Ichthyosis bad-data
Reported results 2013-005083-26 Effect of CD07805/47 gel in subjects presenting with flushing related to erythematotelangiectatic or papulopustular rosacea 2014-06-30 due-trials
Listed as ongoing, but also has a completion date 2014-000710-53 A multicenter open label uncontrolled study of the long term safety and efficacy of calcitriol 3 mcg/g ointment applied twice daily for 26 weeks in pediatric subjects (2 to 16 years and 11 months of a... 2018-05-29 bad-data
Reported results 2014-001744-38 A multicenter, randomized, double blind, parallel group, vehicle controlled, study of the safety and efficacy of calcitriol 3 mcg/g ointment applied twice daily for 8 weeks in pediatric subjects (2 to... 2016-01-18 due-trials
Not reported 2014-001755-23 A LONG-TERM SAFETY AND EFFICACY STUDY OF CD5789 50μg/g CREAM IN SUBJECTS WITH ACNE VULGARIS 2017-02-23 due-trials
Ongoing, reported early 2014-002509-39 Effect of Patient Education on Treatment Adherence and Satisfaction among Acne Patients Receiving Once-Daily EpiduoTM Gel Treatment in Primary Care Clinics not-yet-due
Not reported 2015-001237-24 Subject adherence and satisfaction for treatment of Onychomycosis with Loceryl® Nail Lacquer 5% versus Ciclopoli® Nail Lacquer. 2016-08-25 due-trials
Reported results 2015-001448-13 Benzaknen® 5% Gel in combination with Dermotivin® Soft Liquid cleanser and non-comedogenic Cetaphil® Dermacontrol Moisturizer SPF30 in the treatment of mild-to-moderate acne vulgaris 2016-01-15 due-trials
Not reported 2015-001503-31 Subject adherence and satisfaction for treatment of Onychomycosis with Loceryl® Nail Lacquer 5% versus Canesten® Fungal Nail Treatment Set 2016-09-14 due-trials
Not reported 2015-002540-13 A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50µg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris 2017-06-12 due-trials
Not reported 2016-000063-16 Efficacy and safety of CD5024 1% in acne vulgaris 2016-11-02 due-trials
Listed as ongoing, but also has a completion date 2016-002860-15 A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris 2017-11-16 bad-data
Other 2016-005025-37 A randomized, double-blind, multi-center, parallel-group, placebo-controlled dose-ranging study to assess the efficacy and safety of nemolizumab (CD14152) in moderate-to-severe atopic dermatitis subje... not-yet-due
Completed, but no date 2017-000066-29 Subject reported outcomes on satisfaction, efficacy and safety with Luxerm® in the field-directed treatment of thin or non-hyperkeratotic and non-pigmented Actinic Keratosis of the face or the scalp bad-data
Completed, report not yet due 2017-000157-40 Efficacy comparison of Ivermectin 1% topical cream associated with Doxycycline 40 mg Modified release (MR) capsules versus Ivermectin 1% topical cream associated with Placebo in the treatment of seve... 2018-01-23 not-yet-due
Ongoing 2017-001677-16 A randomized, double-blind, multi-centre, placebo-controlled, parallel-arm phase 2 trial to assess safety, efficacy and pharmacokinetics of CD11301 0.03% and 0.06% gel in the treatment of Cutaneous T-... not-yet-due
Other 2017-001715-36 A study to assess the safety and efficacy of nemolizumab (CD14152) in subjects with prurigo nodularis (PN) not-yet-due